A double-masked, randomized, parallel comparison of a fixed combination of bimatoprost 0.03%/timolol 0.5% with non-fixed combination use in patients with glaucoma or ocular hypertension

被引：2

作者：

Robin, Alan L. ^{[1
]}

机构：

[1] Univ Maryland, Baltimore, MD 21201 USA

[2] Johns Hopkins Univ, Sch Med, Baltimore, MD USA

[3] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA

来源：

EUROPEAN JOURNAL OF OPHTHALMOLOGY | 2007年 / 17卷 / 04期

关键词：

D O I：

10.1177/112067210701700436

中图分类号：

R77 [眼科学];

学科分类号：

100212 ;

摘要：

引用

页码：685 / 686

页数：2

共 50 条

[41] A 12-week, randomized, double-masked study of fixed combination latanoprost/timolol versus latanoprost or timolol monotherapy
Palmberg, Paul
Kim, Elizabeth E.
Kwok, Kenneth K.
Tressler, Charles S.
EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2010, 20 (04) : 708 - 718
[42] Fixed-combination Bimatoprost/Brimonidine/Timolol in Glaucoma: A Randomized, Masked, Controlled, Phase III Study Conducted in Brazil
Belfort Jr, Rubens
Paula, Jayter Silva
Lopes Silva, Marcelo Jordao
Della Paolera, Mauricio
Kim, Thomas
Chen, Michelle Y.
Goodkin, Margot L.
CLINICAL THERAPEUTICS, 2020, 42 (02) : 263 - 275
[43] Multicenter, Randomized, Controlled Study Comparing Tafluprost/Timolol Fixed Combination with Latanoprost/Timolol Fixed Combination in Primary Open-Angle Glaucoma and Ocular Hypertension
Suzuki, Katsuyoshi
Otsuka, Naomi
Hizaki, Hiroko
Hashimoto, Masayo
Kuwayama, Yasuaki
ADVANCES IN THERAPY, 2018, 35 (06) : 796 - 808
[44] Multicenter, Randomized, Controlled Study Comparing Tafluprost/Timolol Fixed Combination with Latanoprost/Timolol Fixed Combination in Primary Open-Angle Glaucoma and Ocular Hypertension
Katsuyoshi Suzuki
Naomi Otsuka
Hiroko Hizaki
Masayo Hashimoto
Yasuaki Kuwayama
Advances in Therapy, 2018, 35 : 796 - 808
[45] A 6-month, randomized, double-masked comparison of latanoprost with timolol in patients with open angle glaucoma or ocular hypertension
Fristrom, B
ACTA OPHTHALMOLOGICA SCANDINAVICA, 1996, 74 (02): : 140 - 144
[46] Preservative-free tafluprost 0.0015%/timolol 0.5% fixed dose combination: a 6-month double-masked, randomized multicenter P-III comparison to concomitant use of the individual preservative-free components in patients with glaucoma or ocular hypertension
Hollo, Gabor
Hommer, Anton
Anton, Alfonso
Ropo, Auli
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
[47] Fixed-combination travoprost 0.004%/timolol 0.5% for open- angle glaucoma or ocular hypertension
Kahook, Malik Y.
Awadallah, Nida S.
Noecker, Robert J.
EXPERT REVIEW OF OPHTHALMOLOGY, 2006, 1 (01) : 25 - 30
[48] Brinzolamide/timolol fixed combination for open-angle glaucoma and ocular hypertension
Hollo, Gabor
EXPERT REVIEW OF OPHTHALMOLOGY, 2009, 4 (02) : 129 - 133
[49] Topical fixed combination brimonidine-timolol therapy for glaucoma and ocular hypertension
Villarrubia, Hector J.
Feldman, Robert M.
EXPERT REVIEW OF OPHTHALMOLOGY, 2007, 2 (05) : 705 - 710
[50] Adherence to Fixed-Combination Versus Unfixed Travoprost 0.004%/Timolol 0.5% for Glaucoma. or Ocular Hypertension: A Randomized Trial
Barnebey, Howard S.
Robin, Alan L.
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2017, 176 : 61 - 69

← 1 2 3 4 5 →